GO:0001974 blood vessel remodeling: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001974 blood vessel remodeling is defined as the reorganization or renovation of existing blood vessels, a process distinct from the initial formation of vessels during vasculogenesis and angiogenesis.
• Blood vessel remodeling is driven by hemodynamic forces, particularly shear stress and circumferential wall stress, which are sensed by endothelial cells and transduced into structural changes.
• Key molecular players include hypoxia-inducible factors (HIFs), vascular endothelial growth factor (VEGF), angiopoietins, matrix metalloproteinases (MMPs), and extracellular matrix (ECM) components.
• Physical inactivity and altered metabolic states, such as increased glycolysis in pericytes, can impair or redirect remodeling, linking lifestyle and metabolism to vascular pathology.
• Dysregulated blood vessel remodeling contributes to ischemic retinopathy, allergic asthma, tumor vascular abnormalities, and cardiovascular diseases.
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of specific genes in blood vessel remodeling.
Description
Blood vessel remodeling (GO:0001974) is the biological process by which existing blood vessels undergo structural reorganization or renovation in response to physiological and pathological stimuli. Unlike vasculogenesis, which creates new vessels from angioblasts, or angiogenesis, which sprouts new capillaries from existing ones, remodeling modifies the architecture, diameter, and wall composition of pre-existing vessels. This process is fundamental to vascular adaptation during development, exercise, wound healing, and in diseases such as cancer and retinopathy. Researchers study blood vessel remodeling to understand how hemodynamic forces, growth factors, and extracellular matrix interactions converge to shape the vasculature. The QuickGO definition captures this as the reorganization or renovation of existing blood vessels, emphasizing that it is a dynamic, context-dependent process rather than a single molecular event. Because remodeling is central to both normal physiology and numerous pathologies, it is a major focus in cardiovascular biology, oncology, and regenerative medicine.
blood vessel remodeling At A Glance
| GO ID | GO:0001974 |
|---|---|
| GO term | blood vessel remodeling |
| Ontology | biological_process |
| Synonym | blood vessel remodelling |
| Definition | The reorganization or renovation of existing blood vessels. |
| Major function | Structural adaptation of existing vessels to hemodynamic and metabolic demands |
| Key triggers | Shear stress, hypoxia, growth factors, inflammatory mediators |
| Related processes | Angiogenesis, arteriogenesis, vasculogenesis, vascular smooth muscle plasticity |
| Disease relevance | Cancer, ischemic retinopathy, asthma, cardiovascular disease |
What Is GO:0001974?
In our own words, blood vessel remodeling (GO:0001974) refers to the active restructuring of already-formed blood vessels. This includes changes in vessel diameter (e.g., outward or inward remodeling), wall thickness, cellular composition (endothelial, smooth muscle, pericyte), and extracellular matrix organization. It is triggered by mechanical forces such as shear stress and wall tension, as well as by biochemical signals like hypoxia, growth factors, and inflammatory cytokines. The process can be adaptive, as in exercise-induced arteriogenesis, or maladaptive, as in tumor vasculature or atherosclerotic plaque neovascularization.
Why Is blood vessel remodeling Important in Cell Biology?
Blood vessel remodeling is critically important because it underlies the vasculature's ability to adapt to changing metabolic and mechanical demands, and its dysregulation is a hallmark of many human diseases. For researchers, understanding the molecular and cellular mechanisms of remodeling provides insights into how tissues respond to ischemia, how tumors build abnormal vasculature, and how chronic inflammation alters vessel function. Moreover, targeting remodeling pathways holds therapeutic potential for conditions ranging from retinopathy to asthma and cancer.
• Enables adaptation to chronic exercise and physical activity by increasing vessel diameter and improving perfusion.
• Mediates recovery from ischemia through arteriogenesis and collateral vessel growth.
• Contributes to tumor vascular abnormalities, which impair drug delivery and promote metastasis.
• Plays a role in allergic asthma by disrupting endothelial-pericyte interactions.
• Is involved in ischemic retinopathy, where semaphorin 3G coordinates β-catenin-dependent remodeling.
• Depends on extracellular matrix turnover and integrin signaling for structural integrity.
• Is regulated by hemodynamic forces such as shear stress and circumferential stretch.
• Dysregulation contributes to atherosclerosis, hypertension, and aneurysm formation.
• Serves as a target for pro- or anti-angiogenic therapies in oncology and ophthalmology.
• Provides a model system to study mechanotransduction and vascular cell plasticity.
What Happens During blood vessel remodeling?
Initiation by Hemodynamic and Metabolic Signals
In simple terms: Blood vessels sense changes in blood flow and oxygen levels, which trigger remodeling.
Blood vessel remodeling is initiated when endothelial cells sense alterations in hemodynamic forces, particularly shear stress and circumferential wall stress. Reduced shear stress or increased wall tension can activate signaling cascades that lead to vessel enlargement or thickening. Hypoxia is another potent trigger; it stabilizes hypoxia-inducible factors (HIFs), which upregulate angiogenic and remodeling factors such as VEGF and angiopoietins. In pericytes, increased glycolysis driven by hexokinase 2 can activate contractility and contribute to tumor vessel abnormalities. Thus, the initiation phase integrates mechanical and metabolic cues to set remodeling in motion.
Endothelial Activation and Matrix Degradation
In simple terms: The inner lining of the vessel becomes activated and enzymes chew through the surrounding matrix to allow structural changes.
Once triggered, endothelial cells become activated, expressing adhesion molecules and secreting proteases such as matrix metalloproteinases (MMPs). MMPs degrade the basement membrane and extracellular matrix (ECM), permitting cell migration and vessel wall reorganization. ECM turnover is a hallmark of remodeling, and its dysregulation leads to vascular stiffness and disease. Endothelial activation also involves changes in cell-cell junctions and interactions with pericytes, as seen in allergic asthma where mast cell activation disrupts endothelial-pericyte interactions.
Proliferation and Migration of Vascular Cells
In simple terms: Cells in the vessel wall multiply and move to build new layers or expand the vessel.
Following matrix degradation, endothelial cells proliferate and migrate, while smooth muscle cells and pericytes are recruited to stabilize the nascent structure. This phase is driven by growth factors such as VEGF, angiopoietin-1 and -2, and platelet-derived growth factor (PDGF). In arteriogenesis, pre-existing collateral arterioles enlarge through endothelial and smooth muscle proliferation, a process that can restore blood flow after arterial occlusion. The balance between proliferation and apoptosis determines net vessel growth or regression.
Lumen Formation and Structural Stabilization
In simple terms: The vessel forms a hollow tube and recruits support cells to make it stable.
As cells organize, a lumen is formed and the vessel wall is stabilized by recruitment of pericytes and smooth muscle cells, along with deposition of new ECM. Semaphorin 3G, an endothelium-derived factor, coordinates β-catenin-dependent remodeling to stabilize retinal vessels. Stabilization also involves tightening of endothelial junctions and restoration of barrier function. In pathological settings, incomplete stabilization leads to leaky, tortuous vessels, as seen in tumors and retinopathy.
Resolution or Progression to Pathology
In simple terms: Remodeling either returns the vessel to a stable state or continues into disease.
In adaptive remodeling, the vessel reaches a new homeostatic set point with improved function, such as after exercise training. In maladaptive remodeling, persistent stimuli drive pathological changes, including vessel wall thickening, fibrosis, and abnormal angiogenesis. For example, in ischemic retinopathy, dysregulated remodeling leads to vision loss, while in tumors, abnormal pericytes and ECM contribute to vessel leakiness and poor perfusion. The outcome depends on the balance of pro- and anti-remodeling signals.
Key Genes Involved in GO:0001974 blood vessel remodeling
The following genes and proteins are central to blood vessel remodeling, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Hypoxia-inducible factor 1-alpha; master regulator of hypoxia responses | Drives expression of VEGF and other remodeling factors |
| VEGFA | Vascular endothelial growth factor A; promotes endothelial proliferation and migration | Key mediator of angiogenesis and remodeling |
| ANGPT1 | Angiopoietin-1; stabilizes vessels and promotes pericyte recruitment | Balances vessel stabilization |
| ANGPT2 | Angiopoietin-2; destabilizes vessels and promotes remodeling | Context-dependent regulator of vascular plasticity |
| MMP2 | Matrix metalloproteinase-2; degrades ECM | Facilitates matrix remodeling and cell migration |
| MMP9 | Matrix metalloproteinase-9; degrades ECM | Involved in pathological remodeling |
| SEMA3G | Semaphorin 3G; endothelium-derived guidance cue | Coordinates β-catenin-dependent retinal vascular remodeling |
| CTNNB1 | β-catenin; transcriptional co-activator | Mediates semaphorin 3G signaling in remodeling |
| HK2 | Hexokinase 2; glycolytic enzyme | Drives pericyte glycolysis and contractility in tumor vessels |
| PDGFB | Platelet-derived growth factor B; recruits pericytes | Essential for pericyte coverage and vessel stabilization |
| TGFB1 | Transforming growth factor beta 1; regulates ECM and smooth muscle differentiation | Modulates vascular wall remodeling |
| NOS3 | Endothelial nitric oxide synthase; produces NO | Regulates vasodilation and shear stress responses |
| VWF | von Willebrand factor; endothelial activation marker | Indicator of endothelial dysfunction in remodeling |
| CDH5 | VE-cadherin; endothelial junction protein | Maintains barrier integrity during remodeling |
| ACTA2 | Alpha smooth muscle actin; contractile marker | Reflects smooth muscle remodeling |
| COL1A1 | Collagen type I alpha 1; ECM component | Contributes to vessel wall stiffness |
| FN1 | Fibronectin 1; ECM glycoprotein | Supports cell migration during remodeling |
| KDR | VEGFR2; receptor for VEGF | Mediates VEGF signaling in endothelial cells |
How Is blood vessel remodeling Regulated?
Blood vessel remodeling is regulated by a complex interplay of mechanical forces, growth factors, and transcriptional programs. Hemodynamic shear stress activates endothelial mechanosensors, including integrins and ion channels, leading to downstream signaling through kinases such as AKT and MAPK. Hypoxia stabilizes HIF1A, which transcriptionally activates VEGF, angiopoietins, and MMPs. The angiopoietin-Tie2 system balances vessel stability and plasticity. In pericytes, glycolytic flux via hexokinase 2 modulates contractility and contributes to tumor vessel abnormalities. Additionally, semaphorin 3G from endothelial cells regulates β-catenin signaling to coordinate remodeling in the retina. ECM stiffness and composition also feed back on cell behavior, influencing remodeling outcomes.
blood vessel remodeling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HK2 | Tumor blood vessel abnormalities | Pericyte-specific knockout in tumor models |
| SEMA3G | Ischemic retinopathy | Endothelial-specific overexpression in mouse retina |
| CTNNB1 | Retinal vascular remodeling | Conditional knockout in endothelial cells |
| MMP2/MMP9 | ECM remodeling in cardiovascular disease | Knockout mice subjected to arterial injury |
| VEGFA | Angiogenesis and tumor growth | Inducible knockout or overexpression in zebrafish/mouse |
Cancer and Tumor Vasculature
Tumors exploit blood vessel remodeling to build an abnormal vasculature that supports growth but is leaky and poorly perfused. Hexokinase 2-driven glycolysis in pericytes activates their contractility, leading to tumor blood vessel abnormalities. ECM remodeling in the tumor microenvironment further promotes vessel dysfunction and metastasis. Targeting these pathways is a major therapeutic strategy.
Ischemic Retinopathy
In ischemic retinopathy, dysregulated blood vessel remodeling leads to pathological neovascularization and vision loss. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling, suggesting a protective role. This pathway is a potential therapeutic target.
Allergic Asthma
Mast cell activation disrupts interactions between endothelial cells and pericytes during early life allergic asthma, contributing to airway remodeling. This highlights how immune cells can modulate vascular remodeling in chronic inflammatory diseases.
Cardiovascular Disease and Physical Inactivity
Physical inactivity leads to impaired blood vessel remodeling, reducing vascular conductance and contributing to cardiovascular risk. Hemodynamic forces and ECM changes also drive atherosclerotic plaque remodeling and arterial stiffness. Understanding these mechanisms is key for prevention and therapy.
From blood vessel remodeling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive endothelial proliferation during remodeling? | Endothelial-specific knockout (e.g., Cdh5-Cre) |
| Does a point mutation in gene Y alter its function in vessel stabilization? | Knock-in of point mutation via CRISPR |
| Does overexpression of gene Z rescue ischemic retinopathy? | Viral or transgenic overexpression in retina |
| What is the role of gene W in pericyte contractility? | Pericyte-specific knockout or tagged knock-in |
| How does gene V affect ECM deposition? | Smooth muscle cell-specific knockout |
| Can CRISPR library screening identify novel remodeling regulators? | Pooled sgRNA library in endothelial cells under shear stress |
How to Study the blood vessel remodeling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function of a gene | Testing causal role in remodeling |
| CRISPR knock-in | Introduction of specific mutations or tags | Modeling human variants or imaging |
| RNA-seq | Transcriptome-wide gene expression | Identifying pathways activated during remodeling |
| Proteomics | Protein abundance and modifications | Discovering novel regulators |
| Intravital microscopy | Real-time vessel structure and dynamics | Visualizing remodeling in live animals |
| Microfluidic shear stress | Endothelial response to flow | Mechanotransduction studies |
| Co-culture assays | Cell-cell interactions | Endothelial-pericyte communication |
| Pooled CRISPR screening | High-throughput gene function | Discovery of remodeling regulators |
Genetic Knockout and Knock-in Models
CRISPR-Cas9-mediated knockout of candidate genes in endothelial or pericyte lineages allows causal testing of their role in blood vessel remodeling. Knock-in of point mutations can mimic human variants or tag endogenous proteins for imaging. These models are often combined with injury or ischemia assays to assess remodeling outcomes.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics of isolated vascular cells before and after remodeling stimuli reveal dynamic changes in gene expression and protein abundance. Single-cell RNA-seq can resolve heterogeneity among endothelial, mural, and immune cells. These approaches identify novel regulators and biomarkers.
Imaging and Hemodynamic Assessment
Intravital microscopy, confocal imaging, and micro-CT enable visualization of vessel structure and remodeling in vivo. Doppler ultrasound and laser speckle contrast imaging measure blood flow and shear stress. These methods link structural changes to functional outcomes.
In Vitro Shear Stress and Co-culture Systems
Microfluidic devices and parallel-plate flow chambers apply controlled shear stress to endothelial cells, mimicking hemodynamic forces. Co-culture with pericytes or smooth muscle cells models cell-cell interactions during remodeling. These systems are amenable to CRISPR screening and live-cell imaging.
How CRISPR Can Be Used to Study GO:0001974 blood vessel remodeling
Knockout
CRISPR knockout of genes such as Sema3g or Ctnnb1 in endothelial cells has been used to demonstrate their essential roles in retinal vascular remodeling. Knockout models allow researchers to assess loss-of-function phenotypes in processes like pericyte recruitment and ECM deposition.
Point Mutation
Introducing point mutations via CRISPR can mimic human disease variants or disrupt specific phosphorylation sites. For example, mutating β-catenin phosphorylation sites can reveal their role in semaphorin 3G signaling during remodeling. Such models are valuable for dissecting signaling mechanisms.
Knock-in
Knock-in of fluorescent tags or reporter genes (e.g., GFP) into endogenous loci enables live imaging of vascular cells during remodeling. Tagged knock-in of ECM proteins can track their deposition and turnover.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of pro-remodeling factors like VEGF or semaphorin 3G can drive or rescue remodeling phenotypes. Overexpression models are useful for gain-of-function studies and therapeutic testing.
How EDITGENE Supports blood vessel remodeling Research
Researchers studying blood vessel remodeling-related genes often need to determine whether a candidate gene is causally involved in vascular reorganization or merely a bystander. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes implicated in blood vessel remodeling.
Contact EDITGENE today to design your custom CRISPR model for blood vessel remodeling research.
Frequently Asked Questions About blood vessel remodeling
What is blood vessel remodeling (GO:0001974)?
Blood vessel remodeling is the biological process of reorganizing or renovating existing blood vessels, as defined by GO:0001974. It involves structural changes in vessel diameter, wall thickness, and cellular composition in response to hemodynamic and metabolic signals.
What genes are involved in blood vessel remodeling?
Key genes include HIF1A, VEGFA, ANGPT1, ANGPT2, MMP2, MMP9, SEMA3G, CTNNB1, HK2, and PDGFB, among others.
How does blood vessel remodeling differ from angiogenesis?
Angiogenesis is the formation of new blood vessels from existing ones, while remodeling refers to the reorganization or renovation of existing vessels without necessarily creating new ones.
What triggers blood vessel remodeling?
Triggers include changes in shear stress, hypoxia, growth factors (e.g., VEGF), inflammatory cytokines, and metabolic shifts such as increased glycolysis in pericytes.
What diseases are associated with abnormal blood vessel remodeling?
Abnormal remodeling is linked to cancer, ischemic retinopathy, allergic asthma, cardiovascular disease, and physical inactivity-related vascular dysfunction.
How can CRISPR be used to study blood vessel remodeling?
CRISPR knockout, knock-in, point mutation, and overexpression models allow researchers to test the causal role of specific genes in remodeling processes.
What is the role of pericytes in blood vessel remodeling?
Pericytes stabilize vessels and regulate contractility; their dysfunction, such as via hexokinase 2-driven glycolysis, can lead to tumor vessel abnormalities.
What is the role of semaphorin 3G in remodeling?
Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling.
How is blood vessel remodeling regulated by hemodynamics?
Hemodynamic forces such as shear stress and wall tension are sensed by endothelial cells and transduced into signaling cascades that drive structural changes.
What experimental models are used to study blood vessel remodeling?
Models include endothelial-specific knockout mice, zebrafish, microfluidic shear stress systems, and co-culture assays with pericytes or smooth muscle cells.
Conclusion
Blood vessel remodeling (GO:0001974) is a fundamental biological process that enables existing vessels to adapt to mechanical and metabolic demands. Its dysregulation underlies major diseases including cancer, retinopathy, asthma, and cardiovascular disorders. Understanding the molecular players and regulatory mechanisms is essential for developing targeted therapies. CRISPR-based models and advanced imaging techniques continue to drive discoveries in this field, offering new opportunities for therapeutic intervention.
References
- 1. Meng YM et al.. 2021. Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities.. Nat Commun 12(1):6011 PMID: 34650057
- 2. Thijssen DH et al.. 2011. Blood vessel remodeling and physical inactivity in humans.. J Appl Physiol (1985) 111(6):1836-45 PMID: 21737819
- 3. Zhang L et al.. 2025. Extracellular matrix in vascular homeostasis and disease.. Nat Rev Cardiol 22(5):333-353 PMID: 39743560
- 4. Secomb TW. 2016. Hemodynamics.. Compr Physiol 6(2):975-1003 PMID: 27065172
- 5. Joulia R et al.. 2024. Mast cell activation disrupts interactions between endothelial cells and pericytes during early life allergic asthma.. J Clin Invest 134(6) PMID: 38487999
- 6. Semenza GL. 2007. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling.. J Cell Biochem 102(4):840-7 PMID: 17891779
- 7. Senger DR et al.. 2011. Angiogenesis.. Cold Spring Harb Perspect Biol 3(8):a005090 PMID: 21807843
- 8. Chen DY et al.. 2021. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating β-catenin-dependent vascular remodeling.. J Clin Invest 131(4) PMID: 33586674
